• Explore /
  • Poster
  • / SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma.

SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma.

Abstract Poster

Authors

Anne Tsao

Anne S. Tsao

The University of Texas MD Anderson Cancer Center, Houston, TX

Anne S. Tsao , Jieling Miao , Ignacio Ivan Wistuba , Nicholas J. Vogelzang , John Heymach , Frank V. Fossella , Charles Lu , Mario R. Velasco , Brandy Box-Noriega , James Gilbert Hueftle , Shirish M. Gadgeel , Mary Weber Redman , David R. Gandara , Karen Kelly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Mesothelioma

Clinical Trial Registration Number

NCT01064648

Citation

J Clin Oncol 36, 2018 (suppl; abstr 8514)

DOI

10.1200/JCO.2018.36.15_suppl.8514

Abstract #

8514

Poster Bd #

120

Abstract Disclosures

Similar Posters

First Author: Peter Wojciech Szlosarek

First Author: Melissa Phillips

First Author: Giorgio V. Scagliotti

First Author: Anne S. Tsao